NCT05066945View on ClinicalTrials.gov

Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients

Not yet recruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Small Cell Lung Cancer Extensive Stage

Interventions

OTHER

Observation

observe the association of ctDNA with efficacy of treatment

All Listed Sponsors

lead

Xiangya Hospital of Central South University

OTHER